ArriVent BioPharma, Inc. (AVBP)
NASDAQ: AVBP · Real-Time Price · USD
18.95
+0.38 (2.05%)
At close: Mar 28, 2025, 4:00 PM
18.67
-0.28 (-1.50%)
After-hours: Mar 28, 2025, 5:16 PM EDT

ArriVent BioPharma Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
Selling, General & Admin
15.39.716.473.02
Research & Development
7964.8830.438.58
Operating Expenses
94.3174.5936.9111.59
Operating Income
-94.31-74.59-36.91-11.59
Interest & Investment Income
13.825.26--
EBT Excluding Unusual Items
-80.49-69.33-36.91-11.59
Pretax Income
-80.49-69.33-36.91-68.81
Net Income
-80.49-69.33-36.91-68.81
Net Income to Common
-80.49-69.33-36.91-68.81
Shares Outstanding (Basic)
31211
Shares Outstanding (Diluted)
31211
Shares Change (YoY)
1369.88%67.64%79.57%-
EPS (Basic)
-2.56-32.38-28.90-96.75
EPS (Diluted)
-2.56-32.38-28.90-96.75
EBIT
-94.31-74.59-36.91-11.59
Updated Mar 3, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q